Last reviewed · How we verify

NCT04991779

AI-assisted cEEG Diagnosis of Neonatal Seizures in Neonatal Intensive Care Unit

Withdrawn Last updated 29 December 2023
What this trial tests

trial testing AI-assisted cEEG detection tool in Neonatal Seizure. Withdrawn.

Timeline
16 March 2022
Primary endpoint
16 May 2022
16 May 2022

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusWithdrawn
Study typeOBSERVATIONAL
Start date16 March 2022
Primary completion16 May 2022
Estimated completion16 May 2022
Sites3 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 0 Days to 28 Days, any sex, with Neonatal Seizure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A diagnostic accuracy study on Artificial intelligence assisted continue EEG diagnostic tool is to carried out comparing with manually EEG interpretation as the golden standard for neonatal seizure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of the clinical effect of an artificial intelligence-assisted diagnosis and treatment system for neonatal seizures in the real world: a multicenter clinical study protocol.
    Xiao TT, Dou YL, Zhuang DY, Hu XH, et al · · 2022 · PMID 35209986 · DOI 10.7499/j.issn.1008-8830.2112124

Verify or expand the search:

Other recruiting trials for Neonatal Seizure

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04991779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing